Sinohealth Holdings's gross profit for the
six
months ended in Jun. 2024 was HK$95.6 Mil. Sinohealth Holdings's gross profit for the trailing twelve months (TTM) ended in Jun. 2024 was HK$257.8 Mil.
Sinohealth Holdings had a gross margin of 55.66% for the quarter that ended in Jun. 2024 => Durable competitive advantage
During the past 5 years, the highestGross Margin % of Sinohealth Holdings was 64.43%. The lowest was 44.61%. And the median was 59.43%.
Sinohealth Holdings Gross Profit Historical Data
The historical data trend for Sinohealth Holdings's Gross Profit can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Sinohealth Holdings's Gross Profit
For the Health Information Services subindustry, Sinohealth Holdings's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sinohealth Holdings's Gross Profit Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Sinohealth Holdings's Gross Profit distribution charts can be found below:
* The bar in red indicates where Sinohealth Holdings's Gross Profit falls into.
Sinohealth Holdings Gross Profit Calculation
Gross Profit is the different between the sale prices and the cost of buying or producing the goods.
Sinohealth Holdings's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as
Gross Profit for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$257.8 Mil.
Gross Profit is the numerator in the calculation of Gross Margin.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Sinohealth Holdings had a gross margin of 55.66% for the quarter that ended in Jun. 2024 => Durable competitive advantage
Sinohealth Holdings Gross Profit Related Terms
Thank you for viewing the detailed overview of Sinohealth Holdings's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.
Sinohealth is a leading provider of Big Data and artificial intelligence-based marketing and distribution information tools, including SaaS-based customer relationship management solutions to mainland China medical product manufacturers. It sources retail data through pharmacy partnerships and provides data analysis to the pharmaceutical and corporate clients it serves. Since its establishment in 2007, its focus has been on building a strong Big Data engine and networking capabilities to assist clients in their product investments and sales and marketing strategies. It is now launching various cloud-based systems and platform solutions for its clients and expanding its SaaS products, which are expected to be the key growth driver in future.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:02361 has been successfully added to your 